UY39670A - Compuestos que tienen tetrahidroindolizina-1-carboxamida como inhibidores de bcl-2 - Google Patents
Compuestos que tienen tetrahidroindolizina-1-carboxamida como inhibidores de bcl-2Info
- Publication number
- UY39670A UY39670A UY0001039670A UY39670A UY39670A UY 39670 A UY39670 A UY 39670A UY 0001039670 A UY0001039670 A UY 0001039670A UY 39670 A UY39670 A UY 39670A UY 39670 A UY39670 A UY 39670A
- Authority
- UY
- Uruguay
- Prior art keywords
- bcl
- inhibitors
- tetrahydroindolizine
- carboxamide
- compounds
- Prior art date
Links
- IKQOMIXIZRXTAQ-UHFFFAOYSA-N 1,2,3,5-tetrahydroindolizine-1-carboxamide Chemical compound C1C=CC=C2C(C(=O)N)CCN21 IKQOMIXIZRXTAQ-UHFFFAOYSA-N 0.000 title 1
- 239000012664 BCL-2-inhibitor Substances 0.000 title 1
- 229940123711 Bcl2 inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 108010090931 Proto-Oncogene Proteins c-bcl-2 Proteins 0.000 abstract 1
- 102000013535 Proto-Oncogene Proteins c-bcl-2 Human genes 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se dirige generalmente a inhibidores de proteínas BCL-2 útiles en el tratamiento de enfermedades y trastornos modulados por dicha enzima y que tienen la Fórmula (I): [Fig.]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163160208P | 2021-03-12 | 2021-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39670A true UY39670A (es) | 2022-07-29 |
Family
ID=83195610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039670A UY39670A (es) | 2021-03-12 | 2022-03-11 | Compuestos que tienen tetrahidroindolizina-1-carboxamida como inhibidores de bcl-2 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11697650B2 (es) |
| EP (1) | EP4304588A1 (es) |
| JP (1) | JP2024508948A (es) |
| KR (1) | KR20230157419A (es) |
| CN (1) | CN116981458A (es) |
| AR (1) | AR125076A1 (es) |
| AU (1) | AU2022233461A1 (es) |
| BR (1) | BR112023017344A2 (es) |
| CA (1) | CA3211637A1 (es) |
| MX (1) | MX2023010692A (es) |
| TW (1) | TW202302585A (es) |
| UY (1) | UY39670A (es) |
| WO (1) | WO2022192703A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2986002B1 (fr) | 2012-01-24 | 2014-02-21 | Servier Lab | Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3008976A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | "nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent" |
| FR3008979B1 (fr) * | 2013-07-23 | 2015-07-24 | Servier Lab | Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2022532335A (ja) | 2019-05-14 | 2022-07-14 | レ ラボラトワール セルヴィエ | ＧＬＹ１０１ＶＡＬ突然変異を有するＢＣＬ－２媒介性ガンの処置に使用するためのＢｃｌ－２阻害剤 |
-
2022
- 2022-03-11 WO PCT/US2022/019998 patent/WO2022192703A1/en active Application Filing
- 2022-03-11 US US17/692,923 patent/US11697650B2/en active Active
- 2022-03-11 UY UY0001039670A patent/UY39670A/es unknown
- 2022-03-11 CN CN202280021064.2A patent/CN116981458A/zh active Pending
- 2022-03-11 AU AU2022233461A patent/AU2022233461A1/en active Pending
- 2022-03-11 CA CA3211637A patent/CA3211637A1/en active Pending
- 2022-03-11 EP EP22768110.3A patent/EP4304588A1/en active Pending
- 2022-03-11 BR BR112023017344A patent/BR112023017344A2/pt unknown
- 2022-03-11 MX MX2023010692A patent/MX2023010692A/es unknown
- 2022-03-11 KR KR1020237034823A patent/KR20230157419A/ko unknown
- 2022-03-11 JP JP2023554297A patent/JP2024508948A/ja active Pending
- 2022-03-11 TW TW111108982A patent/TW202302585A/zh unknown
- 2022-03-11 AR ARP220100567A patent/AR125076A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112023017344A2 (pt) | 2023-09-26 |
| KR20230157419A (ko) | 2023-11-16 |
| EP4304588A1 (en) | 2024-01-17 |
| US11697650B2 (en) | 2023-07-11 |
| CA3211637A1 (en) | 2022-09-15 |
| CN116981458A (zh) | 2023-10-31 |
| MX2023010692A (es) | 2023-09-19 |
| US20220289745A1 (en) | 2022-09-15 |
| WO2022192703A1 (en) | 2022-09-15 |
| TW202302585A (zh) | 2023-01-16 |
| AR125076A1 (es) | 2023-06-07 |
| AU2022233461A1 (en) | 2023-09-07 |
| JP2024508948A (ja) | 2024-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022018811A2 (es) | Inhibidores de la proteína kras g12c y usos de estos | |
| CL2023002973A1 (es) | Compuestos para la inhibición de nlrp3 y usos de estos. | |
| BR112015021999A2 (pt) | inibidores de indoleamina 2,3-dioxigenase (ido) | |
| UY33694A (es) | ?inhibidores de n1/n2-lactama acetil-coa carboxilasa?. | |
| EA201991556A1 (ru) | Ингибиторы фосфодиэстеразы и способы лечения микробной инфекции | |
| BR112014000240A2 (pt) | derivados de benzilamina como inibidores de calicreína plasmática | |
| EA201001523A1 (ru) | Ингибиторы матриксной металлопротеазы на основе арилсульфонамида | |
| BR112015007616A2 (pt) | inibidores de mek no tratamento de doenças por vírus | |
| UY31952A (es) | 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim | |
| HN2012000973A (es) | INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA | |
| BR112014012129A8 (pt) | inibidores heterocíclicos de glutaminase | |
| BR112014013963A2 (pt) | compostos inibidores de metaloenzimas | |
| BRPI0514544A (pt) | ácidos de oxazol-naftila como moduladores de inibidor tipo-1 de ativador de plasminogênio (pai-1) | |
| BR112014012607A2 (pt) | métodos de tratamento usando um inibidor de interferon gama | |
| BR112013031402A2 (pt) | derivados de hidantoína como inibidores de kv3 | |
| UY38670A (es) | Inhibidores de dihidroorotato deshidrogenasa | |
| EA200800777A1 (ru) | Применение сложных эфиров молочной кислоты для улучшения действия пестицидов | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| BR112015022577A2 (pt) | moduladores ship1 e métodos relacionados a esse | |
| EA201291055A1 (ru) | Ингибиторы протеинтирозинкиназной активности и их применение для лечения глазных заболеваний | |
| CL2020003074A1 (es) | Inhibidores de la vía de respuesta al estrés integrada. | |
| CO6592101A2 (es) | Metodos para tratar ulceras de pie de diabetico | |
| BR112023025358A2 (pt) | Inibidores de protease como antivirais | |
| BR112022008938A2 (pt) | Derivados de 1-aminossulfonil-2-carboxipirrol como inibidores de metalo-beta-lactamase | |
| IN2014DN03077A (es) |